Baker Lh
-
- Cancer Treatment and Pharmacology 4
- Lung Cancer Research Studies 3
-
- Lung Cancer Treatments and Mutations 7
-
- Cancer therapeutics and mechanisms 6
-
- Radiopharmaceutical Chemistry and Applications 4
-
- Ovarian cancer diagnosis and treatment 4
-
- Antifungal resistance and susceptibility 3
-
- Infectious Diseases and Mycology 3
- Co-authors
- Richard StephensJ J CostanziJones SeJoseph M. QuaglianaE. GehanTalley RwWeick JkMichael Henderson
- Cited by
- OncologyToxicologyHepatology
- Journals
- Journal of Clinical Oncology (1 paper)Lung Cancer (1 paper)European Journal of Cancer (1 paper)
- Partner nations
- United States
In The Last Decade
Baker Lh
30 papers receiving 267 citations
Peers
Comparison fields: 5 of 64
- Oncology 169
- Toxicology 11
- Hepatology 18
- Pulmonary and Respiratory Medicine 71
- Pathology and Forensic Medicine 35
Countries citing papers authored by Baker Lh
This map shows the geographic impact of Baker Lh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Baker Lh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Baker Lh more than expected).
Fields of papers citing papers by Baker Lh
This network shows the impact of papers produced by Baker Lh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Baker Lh. The network helps show where Baker Lh may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Baker Lh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Phase II trial of diaziquone in patients with refractory and relapsing multiple myeloma: a Southwest Oncology Group Study. | 1987 | 3 |
| 2 | Phase I study of echinomycin. | 1987 | 10 |
| 3 | Phase II trial of diaziquone in advanced large bowel carcinoma in previously treated and untreated patients: a Southwest Oncology Group Study. | 1985 | 2 |
| 4 | PCNU in advanced adenocarcinoma of the ovary: a phase II study. | 1983 | 3 |
| 5 | Gallium nitrate in malignant lymphoma: a Southwest Oncology Group study. | 1983 | 24 |
| 6 | Phase II evaluation of gallium nitrate in breast cancer: a Southwest Oncology Group Study. | 1982 | 7 |
| 7 | Clinical trial of chlorozotocin, DTIC, and dactinomycin in metastatic malignant melanoma. | 1982 | 3 |
| 8 | Phase II study of high-dose intermittent cycloleucine in colorectal malignancies. | 1982 | 2 |
| 9 | Mitomycin C and bleomycin in the treatment of far-advanced cervical cancer: a Southwest Oncology Group pilot study. | 1981 | 13 |
| 10 | Phase I-II clinical trial of gallium nitrate (NSC-15200). | 1980 | 12 |
| 11 | American experience with carminomycin. | 1979 | 10 |
| 12 | Use of VM-26 as a single agent in the treatment of renal carcinoma. | 1979 | 9 |
| 13 | Clinical trial of rubidazone in advanced squamous cell carcinoma of the lung and adenocarcinoma of the large intestine. | 1978 | 2 |
| 14 | Combination chemotherapy with cyclophosphamide, vincristine, methyl-CCNU, and bleomycin in advanced bronchogenic carcinoma: experience with 106 patients. | 1977 | 3 |
| 15 | 5-FU infusion and cyclophosphamide in the treatment of advanced ovarian cancer. | 1977 | 4 |
| 16 | Adriamycin and 5-fluorouracil in the treatment of advanced hepatoma: a Southwest Oncology Group study. | 1977 | 18 |
| 17 | Phase I and II evaluation of cytembena in disseminated epithelial ovarian cancers and sarcomas. | 1976 | 3 |
| 18 | Phase I clinical trial of combined therapy with vinblastine (NSC-49842), bleomycin (NSC-125066), and cisdichlorodiammineplatinum(II)( NSC-119875). | 1976 | 17 |
| 19 | Phase I study of oral mitomycin C. | 1976 | 15 |
| 20 | Bony metastasis from adenocarcinoma of the colon. | 1974 | 8 |
About Baker Lh
Baker Lh is a scholar working on Reproductive Medicine, Small Animals, Oncology, Pulmonary and Respiratory Medicine and Toxicology, having authored 31 papers that have together received 300 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (7 papers), Cancer therapeutics and mechanisms (6 papers), Radiopharmaceutical Chemistry and Applications (4 papers), Ovarian cancer diagnosis and treatment (4 papers), Cancer Treatment and Pharmacology (4 papers), Antifungal resistance and susceptibility (3 papers), Lung Cancer Research Studies (3 papers) and Infectious Diseases and Mycology (3 papers). The work is most often cited by research in Oncology (169 citations), Toxicology (11 citations), Hepatology (18 citations), Pulmonary and Respiratory Medicine (71 citations) and Pathology and Forensic Medicine (35 citations). Baker Lh has collaborated with scholars based in United States. Frequent co-authors include Richard Stephens, J J Costanzi, Jones Se, Joseph M. Quagliana, E. Gehan, Talley Rw, Weick Jk, Michael Henderson, Priyanka A. Shah and Michael K. Samson. Their work appears in journals such as Journal of Clinical Oncology, Lung Cancer, European Journal of Cancer and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.